Abstract
Decay-accelerating factor (CD55) is a complement regulatory protein, which is expressed by most cells to protect them from complement-mediated attack. CD55 also binds CD97, an EGF-TM7 receptor constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells upon activation. Early results suggested that CD55 could further enhance T cell proliferation induced by phorbol ester treatment. The present study demonstrates that coengagement of CD55, using either cross-linking mAbs or its natural ligand CB97, and CD3 results in enhanced proliferation of human peripheral blood CD4+ T cells, expression of the activation markers CD69 and CD25, and secretion of IL-10 and GM-CSF. Recently, an increase in T cell respoesiveness in CD55 -/- mice was shown to be mediated by a lack of complement regulation. To this study, we show that direct stimulation of CD55 on CD4+ T cells with CD97 can modulate T cell activation but does not interfere with CD55-mediated complement regulation. Our results support a multifaceted role for CD55 in human T cell activation, constituting a further link between innate and adaptive immunity.
| Original language | English |
|---|---|
| Pages (from-to) | 1070-1077 |
| Number of pages | 8 |
| Journal | Journal of Immunology |
| Volume | 177 |
| Issue number | 2 |
| DOIs | |
| State | Published - 15 07 2006 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Costimulation via CD55 on human CD4+ T cells mediated by CD97'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver